Solutia Opts to Retain Pharma Business

Solutia has elected to retain its Pharmaceutical Services Division (PSD) despite suggestions that a spin out or sale of the business were being considered, reports Phil Taylor. PSD is made up of two Switzerland-based companies -- CarboGen and Amcis -- and together these companies account for about 2 percent of Solutia's annual sales with turnover of around $50 million. The fact that the companies have been presenting themselves as CarboGen and Amcis rather than Solutia PSD at recent exhibitions -- including last year's CPhI and Informex -- contributed to speculation that a sale could be on the cards.

In Pharma Technologist (http://www.in-pharmatechnologist.com/news/news-ng.asp?n=59502-solutia-opts-to)